USPTO serial 79225174
RINBRI
Reviewed by CopyMark Law Group
Reg. 5494778Status 709
- Filing date
- Status date
- Registration date
- Jun 19, 2018
- Examiner
- CHADAB, SETH WILLIG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RINBRI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | RINX | USPTO CORRECTION PROCESSED BY IB | — |
| May 21, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 5, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 5, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 10, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 3, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 3, 2025 | C71T | CANCELLED SECTION 71 | — |
| Feb 8, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 3, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 3, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 19, 2018 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Jun 19, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 3, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 14, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 1, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 26, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 26, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 22, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 19, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 18, 2018 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |